Chalcones-Sulphonamide Hybrids: Synthesis, Characterization and Anticancer Evaluation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A panel of chalcone-sulphonamide hybrids has been designed by tethering appropriate sulphonamide scaffold with substituted chalcones as a multi-target drug for anticancer screening. Chalcones were prepared by Claisen-Schmidt condensation reaction of a substituted aldehyde with para aminoacetophenone. All the synthesized compounds were evaluated against selected five cancer cell lines, MCF-7 (Breast cancer), DU-145 (Human prostate Carcinoma), HCT-15 (Colon cancer), NCIH-522 (stage 2, adenocarcinoma; non-small cell lung cancer) and HT-3 (Human cervical cancer). Most of the synthesized chalcone-sulphonamide hybrids showed amended cytotoxic activity against various cancer cell lines which may be attributed to the linkage of sulphonamide with chalcone skeleton. The synthesized compounds were characterized by FT-IR, 1H NMR, 13C NMR and HR-LCMS and spectral study assert the structures of synthesized sulphonamide-chalcone hybrids.
Abstract
A panel of chalcone-sulphonamide hybrids has been designed by tethering appropriate sulphonamide scaffold with substituted chalcones as a multi-target drug for anticancer screening. Chalcones were prepared by Claisen-Schmidt condensation reaction of a substituted aldehyde with para aminoacetophenone. All the synthesized compounds were evaluated against selected five cancer cell lines, MCF-7 (Breast cancer), DU-145 (Human prostate Carcinoma), HCT-15 (Colon cancer), NCIH-522 (stage 2, adenocarcinoma; non-small cell lung cancer) and HT-3 (Human cervical cancer). Most of the synthesized chalcone-sulphonamide hybrids showed amended cytotoxic activity against various cancer cell lines which may be attributed to the linkage of sulphonamide with chalcone skeleton. The synthesized compounds were characterized by FT-IR, 1H NMR, 13C NMR and HR-LCMS and spectral study assert the structures of synthesized sulphonamide-chalcone hybrids.
참고문헌 (26)
- Fadeyi, O O., , Bioorg. Med. Chem. Lett, 18, pp.4172~ (2008)
- Hiss, D C., , Expert Opin. Drug Discov, 4, pp.799~ (2009)
- Valiron, O., , Cell Mol. Life Sci, 58, pp.2069~ (2001)
- Colliste, C B., , Anticancer Res, 21, pp.3949~ (2001)
- Ngameni, B., , Med. Chem, 3, pp.233~ (2013)
- Chandrabose, K., , Recent Pat. Anticancer Drug Discov, 10(1), pp.97~ (2015)
- Chimenti, F., , J. Med. Chem, 52, pp.2818~ (2009)
- Kamal, A., , Eur. J. Med. Chem, 46, pp.3820~ (2011)
- Narender, T., , Tetrahedron Lett, 52, pp.5794~ (2011)
- Rajakumar, P., , Tetrahedron Lett, 49, pp.6539~ (2008)
- Suvitha, S., , Molecules, 17, pp.6179~ (2012)
- Ratchanok, P., , Eur. J. Med. Chem, 85, pp.65~ (2014)
- Iqbal, H., , Med. Chem. Res, 23, pp.4383~ (2014)
- Takagi, M., , Invest. New Drug, 21, pp.387~ (2013)
- Supuran, C T., , Med. Res. Rev, 23, pp.535~ (2003)
- Mak, N K., , J. Biomed. Sci, 10, pp.418~ (2003)
- Das, M., , J. Toxicology, 1 (2016)
- Fathalla, O A., , Archives of Pharma. Res, 23, pp.258~ (2002)
- Sapuran, C T., , Med. Res. Rev, 23, pp.146~ (2003)
- Supuran, C T., , Immunol. Endocr. Metab. Agents Med. Chem, 1, pp.61~ (2001)
- Maren, T H., , Annu. Rev. Pharmacol. Toxicol, 16, pp.309~ (1976)
- Chun, W M., , Eur. J. Med. Chem, 77, pp.378~ (2014)
- Hamada, N M. M., , M. Molecules, 20, pp.10468~ (2015)
- Asha V. Chate, "An Improved Procedure for the Synthesis of 1,5-Benzothiazepines Using Ceric Ammonium Nitrate (CAN)", 대한화학회지, 55(5), pp.776~780 (2011), 대한화학회
- Shankaraiah, N., , Bioorg. Chem, 59, pp.130~ (2015)
- Nielsen, S F., , Bioorg. Med. Chem, 12, pp.3047~ (2004)